Base4's drug discovery platform allows its collaborators to evaluate billions of novel small molecules to identify and progress RNA-modulators for important diseases. DURHAM, N.C., Jan. 5, 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results